Adult hypophosphatasia treated with teriparatide: Report of 2 patients and review of the literature

Pauline M. Camacho, Alaleh M. Mazhari, Cory Wilczynski, Ruth Kadanoff, Steven Mumm, Michael P. Whyte

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations

Abstract

Objective: Hypophosphatasia (HPP) is a rare inherited metabolic bone disease from deficient activity of the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). Reportedly, teriparatide (parathyroid hormone 1-34) can benefit the adult form of HPP, including fracture healing. We studied 2 women with adult HPP given teriparatide and reviewed the reports of 6 additional patients. Methods: A 68-year-old black woman (patient 1) described low-trauma fractures and had subnormal serum alkaline phosphatase (ALP) activity. Biochemical findings were consistent with HPP. Mutation analysis revealed a heterozygous defect in exon 10 of TNSALP (ALPL). Teriparatide was injected daily for 2 years. Four years later, she fractured her right hip. Treatment was resumed for 8 months without further fractures. A 53-year-old white woman (patient 2) reported low-trauma fractures and had subnormal serum ALP. Mutation analysis revealed a heterozygous defect in exon 8 of TNSALP. She injected teriparatide daily for 2 years. One year later, bone mineral density (BMD) declined and treatment was resumed for 3 months. When she sustained a sacral fracture, teriparatide was administered for a further 18 months. Results: Patient 1's serum ALP increased while receiving teriparatide and returned to baseline after its discontinuation. BMD remained unchanged, but no fractures were sustained. Patient 2's serum ALP increased, but the improvement was not sustained. Femoral neck BMD increased significantly during the first cycle, declined significantly afterwards, and was regained during a second course of teriparatide. Conclusion: Teriparatide shows some benefit for adult HPP.

Original languageEnglish
Pages (from-to)941-950
Number of pages10
JournalEndocrine Practice
Volume22
Issue number8
DOIs
StatePublished - Aug 2016

Fingerprint Dive into the research topics of 'Adult hypophosphatasia treated with teriparatide: Report of 2 patients and review of the literature'. Together they form a unique fingerprint.

Cite this